Coronavirus China

Coronavirus China

Latest news and updates on the impact of a new strain of coronavirus in mainland China. The virus, which causes the disease Covid-19 was first reported in Wuhan. The authorities introduced sweeping me

Show more
China’s Covid-19 epicenter gets back to normal, but can't hide the trauma
When Wang Dandan moved to Wuhan for a job managing a newly built hotel last summer, she could never have guessed the front-seat view she would have of the city’s battle against the coronavirus. After the severity of the outbreak became clearer and authorities sealed off the central Chinese city on January 23, her hotel became the sleeping quarters for medical professionals deployed across the city. Thanks to its proximity to two major hospitals, the hotel was soon abuzz with doctors and nurses at the initial epicenter of the crisis. The lobby of the hotel is still decorated with silk banners sent by visiting medical teams expressing gratitude for the hospitality. But nearly 150 days after th
China sets out its targets for Covid-19 vaccines
Covid-19 vaccines must protect at least half of those given the injection and provide at least six months’ immunity if they are to be approved for use in China, the country’s drug regulator has announced. According to a draft document released by the Chinese Center for Drug Evaluation (CCDE), 50% is the minimum efficacy rate allowable, although 70% is the target. The document said also that the regulator would consider allowing the emergency use of vaccines that have not yet completed their final phase of clinical trials. Chinese companies are among the frontrunners in the race to produce a vaccine for Covid-19, with four candidates undergoing final testing. A total of 29 products are under
Covid-19 vaccines may be ready in early 2021. That’s a start
With six Covid-19 vaccine candidates undergoing final clinical trials, initial data about whether they can protect people from the disease is expected to be available in the next two to three months, assuming all goes well. That gives hope to the possibility that a vaccine could hit the market by early next year. However, that does not necessarily mean the global community will be out of the woods.  One concern is that, while the possible candidates use different technologies, they have adopted a similar strategy for attacking the SARS-CoV-2 virus.   The worry is that if the one candidate proves to be effective, the chances of the others succeeding are high. But the opposite scenario also a
This Chinese city wants to test all 6 million residents for Covid-19
Chinese health officials announced on Sunday that they would test all residents of the northeastern city of Dalian for Covid-19 as the local authorities scrambled to control the spread of a new cluster of coronavirus infections. Dalian, a port in Liaoning province with over six million people, confirmed 12 new cases of local origin and 14 asymptomatic cases on Saturday. Dalian’s cluster of infections was first reported on Wednesday when a 58-year-old man working at a seafood processing company tested positive. Ma Xiaowei, director of the National Health Commission, led a team to Dalian on Friday night to guide the containment measures. As of Saturday, the contagion link from the city’s clus
Potential Coronavirus vaccines head towards crucial third step
The race for a Covid-19 vaccine has taken on critical importance as the disease continues to charge through the global population, with almost 15 million confirmed cases and nearly 615,000 deaths. The world hopes a vaccine can be a silver bullet out of the crisis, and new results from some of the teams leading development are showing early promising signs. But the real test lies ahead in the final-phase trials, experts say. The new data out on Monday includes a vaccine candidate produced by a team at Oxford University, working in partnership with British firm AstraZeneca. The candidate was safe and induced strong immune responses in combined phase-one and phase-two trials, according to a st
Covid-19 vaccine urgent as few people have antibodies, Chinese study finds
A Covid-19 survey led by China’s top respiratory disease expert has found the country’s population immunity to be at a low level, underlining what researchers called the “urgent need” for a vaccine. The survey tested the presence of antibodies in over 16,000 people who had not fallen ill from the disease in Wuhan, the initial epicenter of the pandemic, and the southern city of Guangzhou. It found only 2.14% and 0.59% of people in the respective cities had Sars-CoV-2 antibodies by the end of April. “The relatively low [level] suggests that prevention and control measures in China are effective,” wrote the researchers, led by respiratory expert Zhong Nanshan, in a letter published in the journ
We may never find the origin of the coronavirus
Scientists with experience tracking virus behavior say the search for the origin of the coronavirus that causes Covid-19 could take years of work and may not reach a definitive conclusion. This is despite a team of WHO experts expected to meet Chinese health officials this weekend to set parameters for an international mission. One obstacle is time itself. Tracking the virus transmission route more than six months after the outbreak was identified in central China will be a herculean task. Exactly how, where and when the pathogen first infected a human is a mystery. The consensus is that Sars-CoV-2, the coronavirus that causes Covid-19, likely came from a bat. It may have found its way into
Massive floods hit a China struggling to recover from Covid-19
After weeks of intense seasonal flooding in southwestern and central China, torrential rains have caused more floods along the Yangtze River, with nearly 300,000 people evacuated in the eastern provinces of Anhui and Jiangxi as homes have been destroyed, roads paralyzed and many left stranded without food or electricity. More than 2,000 homes were damaged by the latest floodwaters, forcing the evacuation of 147,000 people by Tuesday in Anhui, after a week of heavy rainstorms on the country’s eastern coast. In neighboring Jiangxi, more than 151,000 people were evacuated, with nearly 2,000 houses damaged, between Monday and Wednesday, according to state news agency Xinhua. The seasonal floodwa
When coronavirus vaccines are ready, who will get them first?
Several coronavirus vaccine candidates have reached the final phase of human trials and others are not far behind, but who will benefit from them once they are ready for general distribution remains to be seen. The World Health Organisation and political leaders including French President Emmanuel Macron, German Chancellor Angela Merkel and Chinese President Xi Jinping have called for Covid-19 vaccines to be treated as a global public good. But in reality, many countries are striking deals with pharmaceutical firms to make sure they are the first to benefit. One of the vaccines near the head of the pack, developed by researchers at the University of Oxford and licensed to AstraZeneca, could